Tysabri label update: liver injury

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1628, 2008-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tysabri label update: liver injury

Reactions Weekly, Vol. 1, Iss. 1192, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Idiosyncratic drug-induced liver injury: an update on the 2007 overview

By Hussaini S Hyder Farrington Elizabeth Anne

Expert Opinion on Drug Safety, Vol. 13, Iss. 1, 2014-01 ,pp. : 67-81

Informa Healthcare

Access to resources Recommend Favorite

`Topamax' label update: risk of oligohidrosis and hyperthermia

Inpharma, Vol. 1, Iss. 1396, 2003-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Candesartan and acute liver injury

By González-Jiménez D. Varela J.M. Calderón E. Galindo J. González de la Puente M.A.

European Journal of Clinical Pharmacology, Vol. 56, Iss. 9-10, 2000-12 ,pp. : 769-770

Springer Publishing Company

Access to resources Recommend Favorite

Drug-Induced Liver Injury

By Abboud Gebran Kaplowitz Neil

Drug Safety, Vol. 30, Iss. 4, 2007-01 ,pp. : 277-294

Adis International

Access to resources Recommend Favorite